Bristol-Myers Squibb

Traded on the St. Petersburg Stock Exchange
Bristol Myers Squibb (BMS) is an American pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.
Bristol-Myers Squibb stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Bristol-Myers Squibb balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Bristol-Myers Squibb cash flows

Report period2018 2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Bristol-Myers Squibb multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Bristol-Myers Squibb profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Bristol-Myers Squibb assets
Bristol-Myers Squibb cash flows
Bristol-Myers Squibb dividends
3.25%

Bristol-Myers Squibb dividend policy

The company pays dividends quarterly

Bristol-Myers Squibb shares

TickerNameTypeNominal valueISINPrice
BMY:USBristol-Myers SquibbCommon share-US1101221083$54.88
Bristol-Myers Squibb news
26.10.2023
Bristol-Myers Squibb's GAAP net income for 9 months of 2023 was $6.278 billion, up 45.3% from $4.32 billion in the prior year. Revenue declined 3.5% to $33.529 billion from $34.753 billion a year earlier.
Source: {source} pictogram news.bms.com
Pictogram next
27.07.2023
Bristol-Myers Squibb's GAAP net income for 6 months of 2023 was $4.344 billion, up 60.2% from $2.712 billion in the prior year. Revenue declined 4.1% to $22.563 billion from $23.535 billion a year earlier.
Source: {source} pictogram news.bms.com
Pictogram next
27.04.2023
Bristol-Myers Squibb's GAAP net income for 3 months of 2023 was $2.267 billion, up 76.7% from $1.283 billion in the previous year. Revenue declined 2.7% to $11.337 billion from $11.648 billion a year earlier.
Source: {source} pictogram news.bms.com
Pictogram next
03.03.2023
The Bristol-Myers Squibb Board of Directors announced a quarterly dividend of $0.57 per share. The last day to buy securities to receive the dividend is April 6, 2023. The annual dividend yield may reach 3.06%.
Source: {source} pictogram news.bms.com
Pictogram next
All Bristol-Myers Squibb news
General information
Company nameBristol-Myers Squibb
Tags#pharmacy, #s&p500 index
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
Mailing address430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Websitewww.bms.com
Information disclosurewww.sec.gov